Pharmaceuticals
Shocking dosage mix-up forces Ranbaxy to recall generic Liptor in US
08 Mar 2014
Quality concerns about India's $14 billion drug industry have come to the fore after the US FDA banned plants run by Ranbaxy and Wockhardt Ltd from sending drugs to the US, for failure to meet manufacturing standards
May collaborate, not take over Roche: Novartis
03 Mar 2014
Novartis, which holds a third of Roche's bearer shares, has once again scotched reports of acquiring its Swiss rival, Roche
Drug CRO Medpace to be sold to European PE firm Cinven for $915 mn
25 Feb 2014
European buyout firm Cinven Ltd yesterday confirmed that it will acquire pharmaceutical contract research company Medpace Inc for $915 million from CCMP Capital Advisor
Bayer close to bagging cancer drug maker Algeta for $2.9-bn
24 Feb 2014
German healthcare major Bayer AG today said that it is close to completing its $2.9-billion acquisition of Algeta, after 92.17 per cent shareholders of the Norwegian cancer drug maker tendered their shares to the offer
